Pharmafile Logo
Pharmafocus logo
Advanced Search

Alzheimer’s

Showing 15 posts of 151 posts found.

nerves

New study argues the importance of existing anti-inflammatory drugs in fighting dementia

May 3, 2018
Research and Development Alzheimer's, dementia, pharma

Research into dementia has waned in recent times as researchers struggle to pin down concrete advancements, leading to the withdrawal …

News
celgene_1_02

Celgene bucks trend to strengthen neuroscience pipeline

March 21, 2018
Research and Development, Sales and Marketing Alzheimer's, Celgene, Prothena, biotech, drugs, neuroscience, pharma, pharmaceutical

Celgene has gone against industry movement to back out of the neuroscience area by putting down a potential $2.2 billion …

News
top_ten

Top Ten most popular articles on Pharmafile.com this week

March 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines

We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …

News
satu1028-pano_1024_px

EMA set to also revise guidelines of Alzheimer’s trials

February 28, 2018
Medical Communications Alzheimer's, EMA, FDA, biotech, drugs, pharma, pharmaceutical

The EMA, following on from the FDA’s lead earlier this month, has announced that it will revise its guidelines on …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 23, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Alzheimer's, AstraZeneca, Eylea, FDA, Microsoft, Regeneron, Shire, Tremfya, eurordis, multiple myeloma, rare disease

It’s the last Friday of February, and it’s time for another run-down of the most popular stories of the week. …

News
abbviehqe_004_low

AbbVie turns to tau for Alzheimer’s in $1.1bn deal

February 21, 2018
Research and Development, Sales and Marketing AbbVie, Alzheimer's, Voyager, biotech, drugs, pharma, pharmaceutical

Sailing against the prevailing winds in the Alzheimer’s disease space, AbbVie has launched a deal worth a potential $1.1 billion …

News
fda_building_web

FDA weighs up divisive change to Alzheimer’s drug assessment

February 16, 2018
Medical Communications Alzheimer's, FDA, biotech, drugs, pharma, pharmaceutical

Alzheimer’s disease (AD) is an area badly in need of a treatment, the problem is that this prospect seems to …

News
biogen_austria_238

Biogen shares hit by key Alzheimer’s drug concerns

February 15, 2018
Research and Development Alzheimer's, Biogen, MSD, Merck, biotech, drugs, pharma, pharmaceutical

Biogen made investors very nervous after it announced that it was choosing to add an additional 510 patients to its …

News
merckincweb

MSD shuts down Phase 3 trial in prodromal Alzheimer’s

February 14, 2018
Research and Development Alzheimer's, MSD, pharma, verubecestat

Another blow has been dealt to the field of Alzheimer’s research as MSD announces yet another trial failure of a …

News
bi_microparts_image

Boehringer terminates Alzheimer’s candidate after Phase 2 failure

February 12, 2018
Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma

Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Alzheimer's, Apotex, AstraZeneca, Brexit Health Alliance, CDC, Duchenne Muscular Dystrophy, EMA, Italy, Sanofi, amazon, brexit, santhera, top ten

It’s the first Friday of February, and it’s time for another recap of the top ten articles most popular with …

News
blood_testing

New blood test for Alzheimer’s offers hope

February 1, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

To say January was a bleak month for Alzheimer’s research would be something of an understatement: Pfizer ducked out of …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

January 26, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abcam, Alzheimer's, Dr Reddy's, GSK, J&J, JJ, Reckitt Benckiser, Remicade, Sanofi, influenza, opioid crisis, opioids, top ten, valproate

As we come to the end of January, it’s Friday again – time for another rundown of the top ten …

News
aging_-_hand

Senescent cell findings provides Parkinson’s treatment clue

January 25, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

Senescent cells are the dormant state that cells shift to in response to certain stressors, it is thought that they …

News
old_man_bar

Amyloid pathway doubts after latest Alzheimer’s failure

January 25, 2018
Research and Development Alzheimer's, biotech, drugs, pharma, pharmaceutical

There has been another drug failure in a large Phase 3 that once again crushes a hope for a possible …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025